Steady-State Achievement in Citalopram and Escitalopram Dose Reduction

Pharmacokinetics and Steady-State Timing

The pharmacological rule states that steady-state is reached after at least 5 half-lives following each dose adjustment, according to the American Academy of Clinical Psychiatrists 1, 2
For patients taking citalopram or escitalopram, therapeutic drug monitoring (TDM) should be delayed until after reaching the new steady-state, which is at least 1 week after the dose adjustment, as recommended by the American Academy of Clinical Psychiatrists 1, 2

Patients can expect to experience noticeable relief from dose-dependent side effects after several days to a week, as the plasma concentration is expected to be 2.5 times higher at steady-state than after a single dose, according to the American Academy of Clinical Psychiatrists 1, 2
The American Academy of Clinical Psychiatrists recommends waiting at least 5 half-lives (approximately 1 week) after each dose change before performing TDM, to ensure accurate results 1, 2

Blood sampling for level determinations should be correctly timed, with trough levels taken directly before morning dose intake, approximately 12-16 hours (or 24 hours for once-daily dosing) after the last medication intake, as recommended by the American Academy of Clinical Psychiatrists 1, 2
Measuring too early can lead to misleading results that do not reflect the new steady-state, according to the American Academy of Clinical Psychiatrists 1, 2